pharmaceutical compositions containing the substances that inhibit the resorption of noradrenaline, dopamine and serotonin, which are combined with an amino acid for the treatment of obesity and overweight.

摘要

PHARMACEUTICAL COMPOSITIONS CONTAINING THE SUBSTANCES THAT INHIBIT THE REABSORPTION OF NORADRENALINE, DOPAMINE AND SEROTONIN, THAT ARE COMBINED WITH AN AMINO ACID FOR THE TREATMENT OF OBESITY AND EXCESS OF WEIGHT The present invention is related to the pharmaceutical industry in general and the pharmaceutical industry producer of drugs to control obesity and overweight. More specifically, it is a composition formed by a substance that inhibits the reabsorption of noradrenaline, dopamine and serotonin and by an amino acid. The composition is characterized by the fact that the combination or combination consists of a selected substance that inhibits the reabsorption of noradrenaline, dopamine and serotonin known as sibutramine and an amino acid known as L-carnitine, which produce a product with a synergistic effect for the treatment of obesity and overweight with fewer side effects.